Latest Trends in Subpectoral Breast Reconstruction

Abstract

There has been a shift in recent years toward a growing popularity of implant-based breast reconstruction, especially in the setting of increased frequency of concurrent contralateral prophylactic mastectomy. Advancements in implant safety and technology have also allowed for an expanding implant reconstruction practice across the country. The traditional approach is immediate two-stage implant reconstruction with placement of a tissue expander within a subpectoral pocket. The introduction of acellular dermal matrix has revolutionized implant-based breast reconstruction, allowing surgeons the opportunity to minimize morbidity while maximizing aesthetic outcomes. There have also been advances in the management of postoperative pain control as well as secondary revision surgery.

Breast Implant Position and Its Impact on Clinical Outcome in Breast Cancer Patients

“…Implant placement beneath the pectoralis major muscle can lead to loss of its function, known as the "contrived breast" effect, posing the need for physiotherapy [16]. Fat grafting is valuable for reducing pain and deformation animation [18,[63][64][65][66][67][68][69]. On the contrary, prepectoral placement is characterized by a lower postoperative pain and deformation animation rate.…”

Post-mastectomy radiation therapy in breast reconstruction: a patterns of care study of the Korean Radiation Oncology Group

“…Breast reconstruction has become very common over the last two decades [ 1 , 2 ]. It significantly improves the quality of life and reduces adverse psychosocial effects following mastectomy [ 3 ].…”

The Use of Biologic Wound Agents in Pediatric Reconstructions

“…1 While said agents were traditionally employed in burn patients, their onand off-label indications have expanded to include a wide variety of surgeries ranging from reconstructing defects of the face following Mohs micrographic surgery to implantbased breast reconstruction. [2][3][4] The advantages of biologic wound agents are most apparent in pediatric patients where soft tissue discrepancies or deficiencies occur that exceed the amount of donor tissue available. 5 Despite their utility, the use of biologic wound agents to reconstruct defects typically seen in the pediatric population is poorly described in the literature.…”

“…1 While said agents were traditionally employed in burn patients, their on- and off-label indications have expanded to include a wide variety of surgeries ranging from reconstructing defects of the face following Mohs micrographic surgery to implant-based breast reconstruction. 2 3 4…”